CoverageForm 410-K10-Q8-K13D13G13F

AIDX 20/20 Biolabs, Inc. - 8-K

Filed May 26, 2026. See issuer overview · financials · original on SEC.gov ↗
Accession
0001213900-26-061039
3.035.039.01

Item 3.03 - Material Modification to Rights of Security Holders

117 words

Item 3.03

Material Modification to Rights of Security Holders.

On
May 19, 2026, the Board of Directors of 20/20 Biolabs, Inc. (the “ Company ”) adopted Amendment No. 1 to the Company’s
Amended and Restated Bylaws (the “ Amendment ”), pursuant to which Section 2.5 of the Company’s Amended and Restated
Bylaws was amended to reduce the quorum required for a meeting of stockholders from a majority of the shares outstanding to one-third
of the shares outstanding.

The foregoing description of the Amendment does
not purport to be complete and is qualified in its entirety by reference to the full text of the Amendment filed as Exhibit 3.2 to this
report, which is incorporated herein by reference.

Item 5.03 - Amendments to Articles of Incorporation or Bylaws

27 words

Item 5.03

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

The information set forth in Item 3.03 above is
incorporated herein in its entirety.

Item 9.01 - Financial Statements and Exhibits

67 words

Item 9.01

Financial Statements and Exhibits.

(d) Exhibits

Exhibit No .

Description of Exhibit

3.1

Amended and Restated Bylaws of 20/20 Biolabs, Inc. (incorporated by reference to Exhibit 2.3 to the Annual Report on Form 1-K filed on July 6, 2020)

3.2

Amendment No. 1 to Amended and Restated Bylaws of 20/20 Biolabs, Inc.

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

1